Victory Square Provides Update on Hydreight and Healthcare Investments Following FDA Advisory Committee Recommendations on Peptide-Related Bulk Drug Substances
Go back to Victory Square Provides Update on Hydreight and Healthcare Investments Following FDA Advisory Committee Recommendations on Peptide-Related Bulk Drug Substances| (AMEX: VSQTF) | Delayed: 0.32 +0.02 (6.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.30 | 52 Week High | $ | |||
| Open | $0.32 | 52 Week Low | $ | |||
| Day High | $0.32 | P/E | N/A | |||
| Day Low | $0.32 | EPS | $ | |||
| Volume | 3,490 | |||||
| (NYSE: VST) | Delayed: 156.14 +5.82 (3.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $150.32 | 52 Week High | $ | |||
| Open | $153.35 | 52 Week Low | $ | |||
| Day High | $158.74 | P/E | N/A | |||
| Day Low | $151.83 | EPS | $ | |||
| Volume | 5,070,628 | |||||



